Mechanism of inhibition of enveloped virus membrane fusion by the antiviral drug arbidol.
The broad-spectrum antiviral arbidol (Arb) inhibits cell entry of enveloped viruses by blocking viral fusion with host cell membrane. To better understand Arb mechanism of action, we investigated its interactions with phospholipids and membrane peptides. We demonstrate that Arb associates with phosp...
Guardado en:
Autores principales: | Elodie Teissier, Giorgia Zandomeneghi, Antoine Loquet, Dimitri Lavillette, Jean-Pierre Lavergne, Roland Montserret, François-Loïc Cosset, Anja Böckmann, Beat H Meier, François Penin, Eve-Isabelle Pécheur |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Public Library of Science (PLoS)
2011
|
Materias: | |
Acceso en línea: | https://doaj.org/article/b5018ec167664ed6b836c2e03b8ff3e2 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Enveloped viruses distinct from HBV induce dissemination of hepatitis D virus in vivo
por: Jimena Perez-Vargas, et al.
Publicado: (2019) -
Efficacy and safety of arbidol (umifenovir) in patients with COVID‐19: A systematic review and meta‐analysis
por: Behnam Amani, et al.
Publicado: (2021) -
Receptor complementation and mutagenesis reveal SR-BI as an essential HCV entry factor and functionally imply its intra- and extra-cellular domains.
por: Marlène Dreux, et al.
Publicado: (2009) -
Unlike twins: an NMR comparison of two α-synuclein polymorphs featuring different toxicity.
por: Julia Gath, et al.
Publicado: (2014) -
Interactions of SARS-CoV-2 envelope protein with amilorides correlate with antiviral activity.
por: Sang Ho Park, et al.
Publicado: (2021)